Literature DB >> 27468219

Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Ayokunle T Abegunde1, Bashir H Muhammad1, Owais Bhatti1, Tauseef Ali1.   

Abstract

AIM: Advances in genetics and immunology have contributed to the current understanding of the pathogenesis of inflammatory bowel diseases (IBD).
METHODS: The current opinion on the pathogenesis of IBD suggests that genetically susceptible individuals develop intolerance to dysregulated gut microflora (dysbiosis) and chronic inflammation develops as a result of environmental insults. Environmental exposures are innumerable with varying effects during the life course of individuals with IBD. Studying the relationship between environmental factors and IBD may provide the missing link to increasing our understanding of the etiology and increased incidence of IBD in recent years with implications for prevention, diagnosis, and treatment. Environmental factors are heterogeneous and genetic predisposition, immune dysregulation, or dysbiosis do not lead to the development of IBD in isolation.
RESULTS: Current challenges in the study of environmental factors and IBD are how to effectively translate promising results from experimental studies to humans in order to develop models that incorporate the complex interactions between the environment, genetics, immunology, and gut microbiota, and limited high quality interventional studies assessing the effect of modifying environmental factors on the natural history and patient outcomes in IBD.
CONCLUSION: This article critically reviews the current evidence on environmental risk factors for IBD and proposes directions for future research.

Entities:  

Keywords:  Environmental factors; Exposomes; Inflammatory bowel disease

Mesh:

Substances:

Year:  2016        PMID: 27468219      PMCID: PMC4945988          DOI: 10.3748/wjg.v22.i27.6296

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  211 in total

1.  Active and passive smoking in childhood is related to the development of inflammatory bowel disease.

Authors:  Suhal S Mahid; Kyle S Minor; Arnold J Stromberg; Susan Galandiuk
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

2.  Low exposure to sunlight is a risk factor for Crohn's disease.

Authors:  V Nerich; P Jantchou; M-C Boutron-Ruault; E Monnet; A Weill; V Vanbockstael; G-R Auleley; C Balaire; P Dubost; S Rican; H Allemand; F Carbonnel
Journal:  Aliment Pharmacol Ther       Date:  2011-02-20       Impact factor: 8.171

Review 3.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

4.  Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.

Authors:  Tiago Nunes; Maria Josefina Etchevers; Valle García-Sánchez; Daniel Ginard; Eva Martí; Manuel Barreiro-de Acosta; Fernando Gomollón; Maite Arroyo; Guillermo Bastida; Benito Gonzalez; David Monfort; Esther García-Planella; Carolina Figueroa; Julián Panés; Miquel Sans
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

Review 5.  Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

Authors:  Margherita T Cantorna; Brett D Mahon
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

6.  Helminth infections decrease host susceptibility to immune-mediated diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  J Immunol       Date:  2014-10-01       Impact factor: 5.422

Review 7.  Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis.

Authors:  D Turner; A H Steinhart; A M Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 8.  The immune system in human milk and the developing infant.

Authors:  Armond S Goldman
Journal:  Breastfeed Med       Date:  2007-12       Impact factor: 1.817

9.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

10.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

View more
  49 in total

1.  Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease.

Authors:  Mitsuro Chiba; Kunio Nakane; Masafumi Komatsu
Journal:  Perm J       Date:  2019

Review 2.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

3.  Constitutive androstane receptor regulates the intestinal mucosal response to injury.

Authors:  Grace M Hudson; Kyle L Flannigan; Sarah L Erickson; Fernando A Vicentini; Alexandra Zamponi; Christina L Hirota; Laurie Alston; Christophe Altier; Subrata Ghosh; Kevin P Rioux; Sridhar Mani; Thomas K Chang; Simon A Hirota
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

4.  Asymptomatic acute hepatitis E in a female patient with ulcerative colitis.

Authors:  Kazuyuki Suzuki; Ichiro Kumagai; Yuichi Yoshida; Akio Miyasaka; Yasuhiro Takikawa; Ryoichi Kamiya; Kouryo Kondo; Akinobu Kato; Toshimi Chiba; Hiroaki Okamoto
Journal:  Clin J Gastroenterol       Date:  2017-03-28

5.  Effects of ethnicity and socioeconomic status on surgical outcomes from inflammatory bowel disease.

Authors:  Dimitrios Stamatiou; David N Naumann; Helen Foss; Rishi Singhal; Sharad Karandikar
Journal:  Int J Colorectal Dis       Date:  2022-05-13       Impact factor: 2.571

Review 6.  The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease.

Authors:  Christopher A Lamb; Aamir Saifuddin; Nick Powell; Florian Rieder
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

Review 7.  Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.

Authors:  Adi Eindor-Abarbanel; Genelle R Healey; Kevan Jacobson
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

8.  Fabrication and Evaluation of Celecoxib Oral Oleogel to Reduce the Inflammation of Ulcerative Colitis.

Authors:  Nermin M Sheta; Sylvia A Boshra
Journal:  AAPS PharmSciTech       Date:  2021-06-15       Impact factor: 3.246

Review 9.  Inflammatory bowel disease: between genetics and microbiota.

Authors:  Nour Younis; Rana Zarif; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

10.  Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood.

Authors:  Wei-Sheng Chung; Sunny Chung; Chung-Y Hsu; Cheng-Li Lin
Journal:  Front Med (Lausanne)       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.